FDAnews Announces Defending Your Brand From Attack By Drug Counterfeiters and Illegal Diverters Webinar, Nov. 22
Falls Church, VA (PRWEB) November 14, 2013 -- Defending Your Brand From Attack By Drug Counterfeiters and Illegal Diverters
New Strategies for China and Worldwide
**FDAnews Webinar**
Nov. 22, 2013 — 11:00 a.m. – 12:30 p.m. EST
http://www.fdanews.com/Counterfeiting
Counterfeit drugs can destroy in minutes a reputation that took your company years to build. Learn how savvy drugmakers are fighting counterfeiting — and winning.
What’s the difference between a counterfeit $100 bill and a counterfeit drug?
The $100 bill won’t kill someone. The drug might.
It might kill a company’s reputation, too, and trigger multimillion-dollar lawsuits that tie legal teams in knots.
The problem is real for drugmakers. Counterfeit Avastin and Altuzan from abroad may have found its way to oncologists — and patients — nationwide.
Now FDAnews, in conjunction with top legal experts, is presenting a strategy to help drugmakers toughen anti-counterfeiting and anti-diversion efforts and prepare for the future.
Mark the calendar for Friday, Nov. 22, when Rob Reznick and Liz Howard of Orrick Herrington & Sutcliffe show how to build anti-counterfeiting protection strategies into every phase of a company’s operations.
SPECIAL: This webinar will also include updates from October’s important meeting of the drug industry anti-counterfeiting association, the Pharmaceutical Security Institute (PSI), in Shanghai. Rob Reznick is the association’s outside counsel and Corporate Secretary.
In a fast-paced 90-minute “chalk talk,” Mr. Reznick and Ms. Howard will help you:
• Understand the worldwide problem of counterfeit and otherwise illegal medicines from the viewpoint of Rx manufacturers
• Implement best practices for building a solid anti-counterfeiting protection strategy by learning from the mistakes others have made
• Discover the current worldwide status of counterfeit and illegal medicines — origin, prevalence and distribution
• Thwart counterfeiters via better supply-chain management, disruption of illegal distribution routes, Internet strategies and more effective use of the courts
• And much more
Hear the latest counterfeiting stories from China, perhaps the greatest global offender, and learn ways to protect your company and its products. Gain insight into integrating federal and state track-and-trace regulations into supply chain management strategies.
Counterfeiting menaces business … and it’s growing. Drugmakers need tools to secure their supply chain, choke off illegal distribution, disrupt fraudulent Internet sales, and use the courts to maximum effectiveness. Delaying just makes things worse. Register now.
Meet Your Presenters
Rob Reznick is a partner at Orrick, Herrington & Sutcliffe and co-chair of the firm’s Life Sciences Practice, specializing in matters affecting pharmaceutical and other life science companies. Mr. Reznick also represents drug industry clients in connection with Federal Trade Commission investigations and enforcement. Mr. Reznick is outside counsel and Corporate Secretary of the Pharmaceutical Security Institute Inc., a drug-industry trade group dedicated to fighting pharmaceutical counterfeiting.
Liz Howard is a partner in Orrick Herrington’s San Francisco office. Ms. Howard, an IP litigator, counsels drugmakers regarding potential remedies against counterfeiters and sellers of illegal drugs and those in their distribution chain.
Who Will Benefit
Here’s a suggested list of potential participants:
• Drug manufacturing directors
• Global supply chain specialists
• General counsel/outside counsel
• Regulatory affairs and compliance professionals
• Brand managers and crisis management teams
• Security and intellectual property management executives
• Quality assurance directors
• Process development staff
• Labeling and promotions executives
Conference Details
Defending Your Brand From Attack By Drug Counterfeiters and Illegal Diverters
New Strategies for China and Worldwide
**FDAnews Webinar**
Nov. 22, 2013 — 11:00 a.m. – 12:30 p.m. EST
http://www.fdanews.com/Counterfeiting
Tuition
$547 per site -- includes webinar registration and audio cds and transcripts
Easy Ways to Register
Online: http://www.fdanews.com/Counterfeiting
By phone: 888-838-5578 or 703-538-7600
About FDAnews
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www/fdanews.com/Counterfeiting, +1 (703) 538-7665, [email protected]
Share this article